1.
Chinese Journal of Clinical Pharmacology and Therapeutics
;
(12): 1330-1336, 2020.
Artículo
en Chino
| WPRIM
| ID: wpr-1015108
RESUMEN
AIM: To observe the mechanism of celecoxib reversal adriamycin resistance in NK/T cell lymphoma cells. METHODS: SNK6 and SNK6/ADR cells were treated with celecoxib of different concentrations (10, 20, 40, 60, 80, 100 μmol/L), the growth inhibition rate of SNK6 and SNK6/ADR were measured by MTT method. The IC